CT) as indicated in the Table legends. Extracts from GT-primed B6 or bml2 mice were added at final concentrations as indicated in Table legends . Cultures were incubated for 5 d in a humidified atmosphere of 83% Nz, 10% CO2, and 7% 02 at 37°C and fed daily with a mixture of 50% nutritional cocktail and 50% FCS (28) .
Hemolytic Plaque Assay. 7 d after in vivo injection of antigen, or 5 d after culture initiation, spleen cells were washed three times in HBSS, and PFC responses were assayed using sheep erythrocytes (SRBC) coupled with the cross-reacting copolymer, GAT (29) . GA-, GAT-, and GT-specific PFC were determined by subtracting the number of PFC detected in the presence of suitable dilution of GAT from the number of PFC detected on GAT-SRBC in the absence of the specific inhibitor. All assays were performed in duplicate and the number of PFC per culture are reported.
Induction and Elicitation of Delayed-Type Hypersensitivity (DTH) Responses. 6-7 d after immu-
nization, mice were challenged by intracutaneous injection of the dorsal surface of the ear with 10/xg of GAT (contained in 10 #1 of saline) using a 100-/xl Hamilton syringe fitted with a 30-gauge needle. 24 h after antigen challenge, increases in ear thickness were determined using an engineer's micrometer, and the results were expressed in units of 10 -4 in. (27) .
In Vitro T Cell Proliferation. After determination of in vivo ear swelling, draining lymph nodes (inguinal and periaortic) were used as a source of cells for determining the level of antigen-induced T cell proliferation. 4 × 10 s cells were cultured in flat-bottomed microwell plates in a vol of 0.2 ml of modified Click's medium (30) supplemented with fresh 0.5% syngeneic mouse serum. Cultures were stimulated with the indicated doses of GAT or CA. The plates were incubated in a humidified atmosphere of 5% CO2, 95% air for 120 h, and were pulsed with t #Ci of [aH]thymidine (6 Ci/mM; Research Products International Corp., Mr. Prospect, IL) for the final 24 h. Cultures were harvested with a semiautomatic sample harvester, and measurements of trichloroacetic acid-insoluble radioactive material were determined in a Beckman liquid scintillation counter (Beckman Instruments, Inc., Mr. View, CA). Cultures were performed in triplicate and results expressed as A cpm [(mean cpm of antigen-containing cultures) --(mean cpm of antigen-free-"nil"-cultures)], as previously described (27) .
Results

Elicitation of Prima~y GT Responses in bml2
Mice. In >40 inbred strains of mice, representing 23 different H-2 haplotypes and 15 different non-H-2 backgrounds tested by primary or secondary injection of GT, none responded to GT (18, 19, 22, 23) . Merryman and Maurer (22) and Debr~ et al. (18) demonstrated that some outbred Swiss mice responded to GT, although it was not possible to attribute GT responsiveness to a particular haplotype or locus. Although it is possible to selectively inbreed GT responder Swiss mice to ultimately identify the locus or loci involved in GT responsiveness, such procedures, though straightforward, are both time-consuming and costly. Rather than trying to produce a GT-responder phenotype by backcrossing and selection, we chose to look at inbred strains that differ from parental strain mice only by mutation at one or a few loci. Preliminary in vitro screening experiments showed that bml2 mice appeared to make a primary PFC response to GT. As shown in Table I , this was confirmed in vivo (group a) when the injection ofbml2 mice with 100 btg GT resulted in a primary antigen-specific PFC response. In contrast, injection of parental B6 mice (group B) with GT does not elicit a primary PFC response. B6 mice injected with 10 /xg GT as GT-MBSA (group C) show a response of similar magnitude to the brnl2 GT response. In fact, the bml2 anti-GT response is significant (P = 0.001) when compared with nonresponder-nonsuppressor B6 (group B) mice and suppressor BALB/c (group D), 5R (group E), and (BALB/c × B6)FI, (C × B6)F1, (group G) mice. One could always make the argument that as the bml2 mutation was first detected in a (B6 × C)F1 mouse, BALB/c passenger genes may account for GT responsiveness. In fact, this cannot be the case since (C × B6)F1 mice are nonresponders bml2 (group A) GT responsiveness differs significantly (P < 0.005, as determined by ANOVA) from groups B, D, E, and G.
to GT (group G). Furthermore, in (responder × suppressor)F1 hybrid mice of both sexes, GT-responsiveness is dominant as seen in groups H and I of Table I .
Responsiveness of bm l 2 and B6 Spleen Cells to GT and GA Tin Vitro. During the course of our preliminary screening experiments, we noticed that bml2 mice were not responsive to GAT in vitro, as illustrated in Table II . Cultures of B6 spleen cells are responsive to GAT in a 2.5-10 #g dose range (in our laboratory 10 #g is optimum for all CAT responder strains), whereas they are nonresponsive to GT over a similar dose range, although they respond to 2.5 #g GT as GT-MBSA. bml2 mice, on the other hand, respond to GT over a 2.5-10 #g dose range, while remaining totally unable to make an anti-GAT PFC response. These data suggest that the mutation allowing bml2 mice to respond to GT also has an adverse effect on GAT PFC responses.
Failure ofbml2 Mice to Make GT-TsF1. The GT-MBSA PFC responses of B6 (H-2 b) mice cannot be suppressed by preimmunization with GT. B6 mice do, however, produce GT-TsF1 as a consequence of GT priming, although they cannot be suppressed by this or any other GT-TsFx, because they are deficient in the ability to produce functional Ts2 (24) (25) (26) . Although bml2 mice are able to respond to GT challenge, it is possible that they, likewise, make a GT-TsFx. The data in Table III show that B6 mice make a GT-TsF1 that suppresses >80% of the GT-MBSA PFC response of BALB/c mice that normally generate Ts2 as a consequence of exposure to B6 GT-TsF1 (24) . Lymphoid cell extracts from GT-primed bml2 mice show no such suppressive activity. In fact, experiment 2 of Table III shows that bml2 GT-extract markedly enhances the BALB/c GT-MBSA PFC response.
PFCResponsesof (BALB/c × bml2)FlandF2MicetoGT, GA, andGATIn Vitro. The data in Table I show that bml2-related GT responsiveness is inherited as a dominant trait. The data in Table II indicate that bml2 is a GAT-nonresponder strain. Previous reports (20, 21) have shown that responsiveness to GAT is inherited as a dominant trait: a (suppressor × responder)F1 hybrid animal responds to GAT. bml2 mice appear to be GT responders and GAT nonresponders, whereas BALB/c mice are the exact were prepared from their spleens and thymuses, filter-sterilized, and the extract equivalent to 1.5 X 106 cells (1:400) or 7.5 × 105 cells (1:800) was added at culture initiation. GT-specific PFC responses of BALB/c spleen cells to 2.5 #g GT as GT-MBSA on day 5 of culture.
opposite (18) (19) (20) (21) . We asked whether (BALB/c × bml2)F1 hybrid mice are responders to both GT and GAT. The data in Table IV (BALB/c X bml2)F2 mice were immunized in vitro with GT, GA, or GAT, (Table   IV) . Of the 21 mice so far tested, 5 were GAT responders, but nonresponders to GT (as compared with GT-MBSA controls), 12 were responsive to both GAT and GT, whereas 4 were nonresponders to GAT, although remaining responsive to GT. Mice that were nonresponsive to GAT were also nonresponders to GA. Our observed 5:12:4 ratio does not differ significantly (X z ~-0.524, P = 0.773) from the predicted 1:2:1 ratio. Yet, because of the small sample size, our data do not exclude a 9:3:3:1 ratio that one would predict if the gene(s) responsible for GT responsiveness and GAT/GA unresponsiveness segregated as two independent loci.
Cell-mediated Immune Responses to GA and GAT in bin12 Mice. The data shown in Tables II and IV above indicate that bin12 mice respond to GT and not to GA or GAT in the PFC assay. We asked whether this responder/nonresponder PFC status of bml2 is generalizable to other immunological phenomena. Accordingly, GAT PFC responder [B6, BALB/c, (C × B6)Fx] and GAT PFC nonresponder (bin12) mice were immunized with 20 ~g GAT emulsified in Freund's complete adjuvant at the base of the tail. 6 d after immunization, the mice were challenged with 10/Lg GAT (in 10 #1 phosphate-buffered saline) subcutaneously in the dorsal surface of the ear. DTH reactions were assayed by ear swelling 24 h after challenge. The draining inguinal and periaortic lymph nodes were cultured in the presence of 5 or 0.5/~g GAT for 96 h, whereupon T proliferative responses were measured by tritiated thymidine incorporation. In addition, GAT-specific splenic PFC of these same mice were enumerated on the day of DTH measurement. Data from these experiments show GAT PFC responder mice [B6, BALB/c, and (C × B6)Fll show very good DTH and T proliferative responses as well as anti-GAT PFC responses (Table V) . bin12 mice, on the other hand, show significantly diminished DTH responses and background levels of GAT-specific PFC, but no decrease in the T proliferative response to either 5 or 0.5 /xg of GAT in vitro. These results indicate that bm 12 mice are GAT nonresponders for PFC and DTH responses, while showing T proliferative responses equal to that of B6 mice. There are several important points that have to be dealt with in regard to these findings. First, the ear swelling assay is not a measurement of anti-GAT DTH responses, but rather is a result of an Arthus-type reaction, and lack of ear swelling would be a result of the lack of antibody that would mediate the immune complex reaction. Experiments performed in GAT-responder mice (not shown) indicate that ear swelling is not antibody-mediated; no ear swelling is seen at 4 h postchallenge, the usual time period for appearance of Arthus. We feel that the lack of 4-h ear swelling and the ability to transfer the reaction by cells (data not shown) rules out an Arthustype reaction. Further experiments are in progress to clarify this matter. Second, bml2 mice show T proliferation to GAT, although they are unable to make an anti-GAT PFC or DTH response. This would indicate that the proliferating T (Tp~olif) cell population is distinct from the DTH cell, raising the possibility that the genetic lesion in bml2 mice is not a result of the lack of the Tp~o~ cell is generally held to be a Th cell. The lack of both GAT PFC and DTH responses in bml2 may not be a result of a lack of Tp,ol~, but of the lack of a suitable target for the Th. The data in Table II show that bml2 mice can make very good anti-GAT-MBSA PFC responses, indicating that they possess GAT-specific B cells. One would then have to hypothesize that there may be an intermediate cell between the Th and B cell, such as a Th2 cell. Our laboratories are currently investigating this possibility.
Discussion
Mutant or abnormal genetic variants have been extremely useful in the genetic characterization of many biological systems. The bml2 variant arose as a gain/loss type spontaneous mutation like other mutants of the bm series. However, bml2 is unique among bm mutants in that it is the only strain so far described with a mutation localized to the /-A-subregion of the H-2 complex. The bml2 mutant exhibits a number of functional differences relative to the parental B6 strain with regard to graft rejection (7), Ia antigen expression (8, 12, 13, 31, 32), mixed lymphocyte reaction (8) , and loss of responsiveness to various antigens under Ir gene control (11, (14) (15) (16) (17) 33) . This study is the first to report the establishment of responder status as a consequence of mutation (to GT), while causing loss of responsiveness to a closely related antigen (GAT). Our data show that, because of a mutation affecting theA~ chain of the I-A molecule, bml2 mice have the ability to respond to GT and lost the ability to make a PFC or DTH response to the closely related copolymer GAT. This is in sharp contrast to the parental B6 strain, which is a GT nonresponder and a GAT responder. Furthermore, this is the first report of an inbred GT-responder strain.
Previous reports (18, 22) have shown that some outbred Swiss mice were responsive to GT immunization, however, this trait could not be directly attributable to any particular H-2 or non-H-2 genes. In the present study, bml2 mice have been shown to be PFC responders to GT in contrast to parental B6 mice. The bml2 and B6 strains differ presumably only by the A~ chain of the I-A molecule. Therefore, we are able to ascribe GT responsiveness to the I-A subregion and, presumably, to the I-A molecule of H-2. At the same time, we have observed a greatly diminished ability to make a GAT-speeific DTH responses or GA/GAT-specific PFC responses by bml2. GA/GAT responsiveness must also result from the same gene encoding the A~ molecule. Our observation confirms and extends the recent report of Baxevanis et al. (34) by mapping GA responsiveness to the A~ molecule encoded by the I-A subregion. GT responsiveness is transmitted as an autosomal dominant trait (Tables I and IV) , much the same as has been reported for GAT responsiveness (19) . GT responsiveness does not preclude GAT responsiveness in (C × B6)F1 mice, Table IV, suggesting that the responses associated with the AO molecules of both parental haplotypes are seen in the F1 hybrid mice. This observation is in accord with classical observations that Ia antigens are codominantly expressed in F1 animals (4) (2, 34) and GT responsiveness (this paper), it is most likely that GT-GA/GAT responsiveness is controlled by a single locus or two closely-linked loci. We are currently making the appropriate backcrosses to resolve this question.
Previous studies have shown a heterogeneity in Is gene defects in GT-nonsuppressor strains of mice (24, 25) . Briefly, GT-nonsuppressor mice can be divided into two categories depending upon which ls gene they lack. H-2 a haplotype mice lack the ability to produce a suppressor T cell factor (GT-TsFI) after GT injection, but can be readily suppressed when injected with GT-TsF1. In H-2 b haplotype mice, such as B6, GT injection results in GT-TsF1 production, although these mice lack a functional target cell for the factor (i.e., Ts2). In the present study, we asked whether bml2, a GT-responder strain, can produce a GT-TsFa like parental B6 mice. The data in Table III above show that bin12 mice do not produce GT-TsF1. Since B6 GT-TsF1 bears antigenic determinants of the I-J b subregion (24) , our present data indicate that a gene in the I-A subregion influences production of I-jb-bearing GT-TsF1. If the bin12 variant bears a single mutation affecting only that gene encoding the Ap chain of the I-A molecule, then this same gene or its product(s) must influence gene(s) or the cells expressing gene products of the I-J subregion.
Although bin12 mice are low or nonresponders to GAT by either the PFC or DTH responses, they must also be classified as GAT responders in the T cell-proliferation assay, when compared with parental B6 mice (Table V) . Since we see a close parallel between lack of DTH responses and PFC against GAT in bml2 mice, it could be argued that the ear swelling reaction reflects an Arthus-type reaction and not DTH. We don't believe this to be the case as we see no significant ear swelling above background within 4 h postchallenge (data not shown). In either case, lack of PFC or DTH responses in brnl2 mice cannot be predicted by the T cell-proliferation assay. A precedent already exists for the disparity between humoral immunity and proliferative responses to antigens under/r gene control. Merryman and Maurer (22) reported that H-2 b'a'f'k'r'~ haplotype mice make antibody responses to GA, whereas H-2 j'p'q do not. Baxevanis et al. (34) , using the very same antigen in a T cell proliferation assay, reported that H-2 r'~ mice are nonresponders to GA. From our present data, we propose several possible mechanisms that may account for the discrepancy between T cell proliferative responses and PFC vs. DTH responses: (a) The Tp~o~ is not the efferent Th cell (Theu) for PFC response, suggesting that the Tpro~ is an afferent Th (The) cell. This would necessitate a two-step mechanism for help much the same as has been demonstrated for Ts, where a Tsl cell induces or stimulates a Ts2 via TsF1 (26) . In fact, several investigators have proposed models involving multiple Th cells in regulatory cellular circuits for humoral immunity (35, 36) and DTH responses (37) . We propose that the Th~ is the GAT TproUf cell and that its ability to incorporate tritiated thymidine is not under Ir gene control and is not affected by the bml2 mutation. The Th,n, on the other hand, would appear to be the site of the functional It/Is gene lesion(s); this cell would be defective in its ability to deliver an adequate help signal to the DTH effector cell or to the B cell. Lack of functional Thee activity could be a result of either clonal deletion similar to the model recently proposed by Schwartz (38) or of active suppression of Three function. Clonal deletion would necessitate that pre-Thett clones bearing receptors for GT/GAT plus A# in B6/bml2 mice mimic anti-self and are selectively deleted during ontogeny. It must be restated that the bml2 does not appear to have a defective GAT-specific B cell, as bml2 mice make a very good GAT-specific PFC response to GAT-MBSA (Table II) . (b) If the Tp~o~ is the same as the Th cell for a PFC response, then it must be unable to communicate an effective help signal to the DTH effector cell or the B cell--indicating that the A# molecule is involved in direct T-T cell (in DTH) or T-B cell (in PFC) interactions, and may serve as a recognition unit for this collaboration. (c) GAT proliferative response in bm 12 mice may not reflect the proliferation of T cells directly involved in T cell help, rather they may be cells involved in Ts induction. One would predict that the Ts-inducer cell proliferation would yield a GAT-specific TsF in bml2 mice. Experiments currently in progress are addressing the question whether bml2 mice produce GAT-TsFa. On the hand, bml2 mice do not make GT-TsF as parental B6 mice do (Table III) , indicating that the proposed GT-specific Ts-inducer cell population must express the A# molecule.
Several ramifications of the bml2 genetic variation on GAT and GT immune responses become apparent. The alteration of the Ag molecule in brnl2 causes loss of primary GAT PFC and DTH responsiveness, while, at the same time, resulting in GT PFC responsiveness. That a single mutation would have opposite effects on immune responses to closely related antigens suggests a bottleneck in the cellular immune mechanisms responsible for GT and GAT responses. We know that bml2 mice can make a B cell response to GAT-MBSA, indicating that these mice do not possess defective B cells (Table II) . Furthermore, Fathman et al. (14) have shown that (bml2 × B6)Fx spleen cells can effectively present GAT to (B6 × A)F1 GAT-or (T,G)-A--Lreactive T cell clones. They concluded that alteration of theA~ chain does not modify the T cell restriction site for some of the GAT epitopes, indicating normal antigen presentation (i.e., macrophage) function for GAT. Similarly, Pierce and Kapp (39, 40) and Clark et al. (41) have demonstrated that macrophages from nonresponder mice can stimulate GAT-specific helper T cells in responder mice. Since neither macrophages nor B cells appear to be responsible for GAT/GT responsiveness, we must assume that the bottleneck lies in the T cell component of the immune response. The evidence presented in this study suggests that the bottleneck is not at the level of the Tp~o~ cell. Strassmann et al. (37) have proposed two distinct Th in (T,G)-A--L DTH responses, one cell acting at the education stage (hence The) and the other at the efferent phase (Three) of DTH. With regard to GAT responsiveness, we propose that bml2 mice are functionally deficient in Theee, although they possess normal The. This GAT-specific Theee would be the efferent Th cell (or cells) for both DTH and PFC reactions, and functionally distinct from the Th~ (or Tprout) cell. The GT-specific Th~ and Theee appear to function normally in the bml2 strain, whereas one or both of these cells may be deficient in the parental B6 strain. On the other hand, the B6 mouse, a GT-nonsuppressor strain, possesses very inefficient GT-specific Th cells.
Evidence for this comes from the observations that B6 mice treated with cyclophosphamide can make a PFC response upon secondary challenge with GT in vivo (C. Waltenbaugh, unpublished observation) and that in vitro treatment of B6 spleen cells with monoclonal anti-I-J b antibody allows the development of GT-specific PFC responses (42) . We propose the following model to account for GAT/GT responsiveness for both B6 and bml2 strains: (a) Both B6 and bml2 strains possess normal Th~ (i.e., Tp,olif) for GAT (bml2 proliferative T cell responses are, as yet, undetermined for GT). (b) That the A~ molecule is necessary for T-T cell interaction/recognition between the Tp~om and its target cell(s), either Tsl or Then, for both GAT and GT. (c) Both GAT-and GT-specific Ts and Then recognize different regions of the same A~ chain of the I-A molecule with opposite effects. We propose that the GAT-specific Theft must recognize the same portion of the At~ molecule as GT-speeific Tsl. Therefore, the mutation that would impair the generation of GAT-specific Th~e~ would also render the bml2 animal incapable of generating GT-TsF1. Conversely, a different region of the At~ chain (or the A~ chain) of the I-A molecule, unaffected by the bml2 mutation, must be responsible for generation of both GT-specific Then and GATspecific Tsx. If B6 GT-specific Theft cells are weak or inefficient, they may be easily suppressed by B6 GT-TsF1 directly without requiring amplifying Tsz cells. Pretreatment of B6 mice with either anti-I-J b or cyclophosphamide may remove this low-level suppression, thus allowing B6 mice to make an anti-GT PFC response. We are currently investigating the possibility that both the bml2 and B6 strains are capable of making GAT-TsF1, indicating that neither strain has a defect in its ability to make GAT-TsF1, as the model would predict. In the (BALB/c × bml2)F1 animal, we see the dominance of response to both GT and GAT, which is in accord with the observations that in (responder X suppressor)F1 hybrids, response predominates (2, 4, 20) . Thus, our model would predict that different antigens may be recognized by different T cell populations in the context of the same Ia gene product.
Summary
The development of inbred strains of mutant mice has proven useful in ascribing specific gene functions to particular genetic loci within the regions and subregions of the H-2 complex. The B6.C-H-2 nmI2 (bml2) strain is of particular interest in that, compared to parental C57BI/6Kh (B6) mice, it bears a presumptive single gene mutation altering the A~ chain encoded by the I-A subregion. Our data show that bml2 mice have gained the ability to respond to poly(Glu~-I'yr ~) (GT) and have lost the ability to make plaque-forming cell or delayed-type hypersensitivity responses to the closely related copolymer, poly(Glu6°Alaa°Tyr 1°) (GAT), although retaining the ability to mount a GAT-specific T cell proliferative response. This is in sharp contrast to the parental B6 strain, which is a GT nonresponder and a GAT responder. Thus, this study is the first to report the establishment of responder status as a consequence of mutation. Possible mechanisms accounting for the gain/loss of GT/GAT responsiveness in the context of a two-step helper T cell model are discussed.
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